Use case · Target–disease association
Know how strong the link between a target and a disease really is
Causaly gathers the genetic, expression, functional and clinical evidence connecting a target to a disease, scores each line of evidence and shows what supports the link, what contradicts it and what is still missing.
Why it matters
A weak association is expensive to discover late
Programs often rest on a target–disease link that looked convincing in a handful of papers. Assessing every link the same way, with the counter-evidence in view, lets teams rule targets in or out earlier.
See the whole evidence base
Literature, Bio Graph relationships, GWAS signals and connected databases such as Open Targets are read together, not searched one at a time.
Judge strength, direction and context
Each line of evidence is graded with the disease context, tissue and direction of effect it applies to, so a link found in one setting isn’t mistaken for another.
Decide with the gaps in view
Contradicting findings and missing evidence sit next to the supporting data, so reviewers can challenge a conclusion before it reaches a portfolio decision.
What it is
What is target–disease association analysis?
Target–disease association analysis asks how strongly, and in which direction, a gene or protein is linked to a disease. It weighs human genetics, expression in relevant tissues, functional and animal-model studies, and clinical and pharmacological evidence.
It is narrower than a full target assessment, which adds tractability, safety and competitive questions. It is usually the first test a target has to pass. For the wider decision, see target identification and prioritization.
648M+
scientific relationships across Bio Graph and Pipeline Graph
40M+
biomedical publications and preprints
225K
GWAS variants with gene context
Indexed content as of October 2026. New literature reaches Bio Graph within about four weeks of publication.
How it works
How Causaly assesses a target–disease link
Ask a question in Agentic Research, or run the Target-Disease Evidence Assessment workflow with a target and a disease. Causaly works through each line of evidence and returns a cited, scored report.
Input
A target and a disease
Add the context that matters to you, such as a subtype, tissue or patient population.
Evidence
Each line of evidence, researched separately
Genetics, expression, functional and animal-model studies, and clinical and pharmacological data come from Bio Graph, the literature and connected sources such as Open Targets, gnomAD and ClinVar.
Assessment
Scores, with the counter-evidence alongside
Each line gets a score and a short rationale, and the report ends with a recommendation and the gaps your team could test next.
Output
A report you can question and share
Ask follow-up questions on the report and export it to Word, PDF or PowerPoint.
Key capabilities
What your team can do with Causaly
From a single target–disease question to a shortlist of candidates, every answer is built on Causaly’s own evidence foundation and checked by citation.
Assess one target against one disease
Run the Target-Disease Evidence Assessment workflow for a consistent, scored report every time, so links can be compared across programs.
Compare candidate targets
Ask Agentic Research to set several targets for the same disease side by side on the same criteria, with every claim cited.
Check the human genetics
Read GWAS evidence with gene context alongside Open Targets, gnomAD and ClinVar, reached through Causaly’s connectors.
Look at expression and pathways
Bring in expression data from Human Protein Atlas and GEO, and pathway and interaction context from Reactome and STRING.
Go further when a link holds up
Follow up with the Target Biology Profile or Target Safety Profile workflows, or ask questions of the report itself.
Keep up with new evidence
Change detection and notifications flag when the evidence behind a question changes, with the source of each change.
Optional: connect internal data through the Enterprise Data Fabric or your own MCP connectors, so your team’s findings are read alongside the public evidence.
“One of the most valuable things about Causaly is that it doesn't cost you time in the lab. You can find something on the platform and look at the experiments performed; what are the methods used, can they be reproduced, do you agree with the results. This helps with understanding what validation experiments to conduct.”Data Science Specialist · Top 20 pharma
Explore more
Related use cases and products
Target identification and prioritization
Move from a disease to a ranked shortlist of targets worth pursuing.
Disease pathophysiology
Map the mechanisms behind a disease before choosing where to intervene.
Biomarker discovery
Find and compare biomarkers to stratify patients and track response.
Scientific Workflows
Repeatable, cited methods for target, disease and preclinical questions.
Agentic Research
Research agents that plan, search and reason across the evidence, citing every claim.
Bio Graph
Cause-and-effect relationships between genes, diseases, drugs and mechanisms.
Target–disease association: common questions
How does Causaly score the strength of an association?
The Target-Disease Evidence Assessment workflow assesses each line of evidence separately, scores it with a short rationale and closes with an overall recommendation. Every score links back to the sources it is based on.
Which data sources does Causaly use?
Bio Graph and Pipeline Graph (648M+ scientific relationships), more than 40 million publications and preprints, and GWAS variants with gene context. Agentic Research can also query connected sources such as Open Targets, gnomAD, ClinVar, Human Protein Atlas, GEO, Reactome and STRING.
How is this different from a full target assessment?
An association analysis asks whether, and how strongly, a target is linked to a disease. A full assessment adds tractability, safety, biology and the competitive landscape. Causaly covers both, with workflows such as Target Biology Profile and Target Safety Profile.
Can I assess several targets at once?
Each workflow run assesses one target against one disease, so results stay comparable from run to run. To compare several targets, run the workflow for each one, or ask Agentic Research to compare them on the same criteria.
Can Causaly use our internal data?
Yes, as an option. Internal documents can be connected through the Enterprise Data Fabric, and your own MCP connectors can be added to Agentic Research. Causaly does not use customer data to train models.
Bring a target and a disease your team is weighing
We’ll run the assessment with you and walk through the scored, cited report, line by line.